NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Peyer10% Owner2025-12-09395$6.40
$2.53kBuy
James Peyer10% Owner2025-12-09446$7.92
$3.53kSell
Cambrian Biopharma Inc10% Owner2025-12-093,105$8.59
$26.67kSell
Cambrian Biopharma Inc10% Owner2025-12-092,666$7.95
$21.19kSell
Cambrian Biopharma Inc10% Owner2025-12-09395$6.40
$2.53kBuy
Cambrian Biopharma Inc10% Owner2025-12-09395$8.04
$3.18kSell
Cambrian Biopharma Inc10% Owner2025-12-09446$7.92
$3.53kSell
James Peyer10% Owner2025-12-092,666$7.95
$21.19kSell
James Peyer10% Owner2025-12-09395$8.04
$3.18kSell
James Peyer10% Owner2025-12-083,105$8.59
$26.67kSell

1 of 2

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer398.68%5,343,479$139.04MInsider
Hs Investments I LP330.23%4,425,998$115.16MInsider
Thomas G. Ricks51.16%685,632$17.84MInsider
Cambrian Biopharma Inc11.58%155,142$4.04MInsider
John Celebi7.90%105,862$2.75MInsider
Robert Hamilton Pierce7.05%94,463$2.46MInsider
Erin Colgan5.03%67,462$1.76MInsider
Der Horst Edward Van4.46%59,794$1.56MInsider
Patrick Stephen Gallagher2.55%34,130$888.06kInsider
Bob Holmen1.91%25,598$666.06kInsider

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE0.43%99.57%Net Selling
IGC4.89%21.78%Net BuyingNet Buying
TVGN3.05%96.95%Net SellingNet Selling
RNTX22.93%77.07%Net Buying
SNTI17.99%82.01%

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 3.60% institutional shareholders, 825.07% Sensei Biotherapeutics insiders, and 0.00% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 5.34M shares representing 398.68% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $126.96M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.